secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0000950170-23-000351
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus receives Nasdaq delisting notice for bid price non-compliance; hearing requested
--------------------------------------------------------------------------------

- Nasdaq Staff determined to delist CRBP for failure to maintain $1.00 minimum bid price; company will request hearing to stay suspension.
- Stockholders approved reverse stock split (1:4 to 1:40) on Dec 20, 2022; board to set exact ratio to potentially regain compliance.
- Previous 180-day compliance period ended Jan 3, 2023 without cure; company had transferred to Nasdaq Capital Market in July 2022.
- If delisted, trading liquidity, financing ability, and investor confidence could be adversely affected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023000351/0000950170-23-000351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023000351/crbp-20230104.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer